We are happy to announce that VentriLabs will be participating in the prestigious Testa Challenge. This recognition highlights VentriLabs’ commitment to advancing cutting-edge technologies in the bioprocess industry. The company’s innovative pump technology solution will now have the opportunity to be rigorously tested and evaluated in a real-world bioprocessing environment. This marks a significant milestone in the efforts of developing the pump for the bioprocess industry.

Being offered to participating in the prestigious Testa Challenge is a testament to VentriLabs’ dedication to pushing the boundaries of what is possible in bioprocessing. By joining this challenge, VentriLabs will have the chance to showcase its technologies in a real-world setting. VentriLabs will gain valuable insights and feedback that will accelerate its path to market. “We hope to be able to demonstrate the positive impact of our innovative technology on the production and purification of monoclonal antibodies for the biopharmaceutical industry” – says Robin Öz, CEO of VentriLabs.

About the Testa Challenge

The Testa Challenge is an annual competition organized by the Testa Center, a state-of-the-art bioprocessing facility that is part of Cytiva, a global life sciences leader. The challenge offers innovators a unique opportunity to evaluate and refine their bioprocess technologies in a real-world industrial setting. Participants are given access to cutting-edge equipment and expertise, allowing them to test their innovations under actual bioprocessing conditions. Learn more about Testa Center – www.testacenter.com